TCL Archive Tesetaxel Showed 20 Percent Response In Second-Line Therapy In Phase IIb Trial January 27, 2012
TCL Archive In Brief: ONS Forms Six New Special Interest Groups; Four Named To Michigan Breast Cancer Center April 13, 1990